Literature DB >> 12450145

Inhibition of proteasome activity by tyropeptin A in PC12 cells.

Isao Momose1, Ryuichi Sekizawa, Hironobu Iinuma, Tomio Takeuchi.   

Abstract

Tyropeptin A, a potent proteasome inhibitor not reported before, was produced by Kitasatospora sp. MK993-dF2. In this study, we investigated the effects of tyropeptin A on proteasome activity in PC12 cells. Tyropeptin A inhibited the intracellular proteasome activity in a dose-dependent way and seemed to cause neurite outgrowth. As expected, ubiquitinated proteins that should be substrates for the proteasome accumulated in cells treated with tyropeptin A. Hence, it appears that tyropeptin A can permeate into cells and there inhibit the intracellular proteasome activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450145     DOI: 10.1271/bbb.66.2256

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice.

Authors:  Takuya Oshikawa; Hayato Kuroiwa; Ryohei Yano; Hironori Yokoyama; Naoto Kadoguchi; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

2.  Automated in vivo drug screen in zebrafish identifies synapse-stabilising drugs with relevance to spinal muscular atrophy.

Authors:  Ana-Maria Oprişoreanu; Hannah L Smith; Sophia Krix; Helena Chaytow; Neil O Carragher; Thomas H Gillingwater; Catherina G Becker; Thomas Becker
Journal:  Dis Model Mech       Date:  2021-04-26       Impact factor: 5.758

3.  Nostocyclopeptides as New Inhibitors of 20S Proteasome.

Authors:  Anna Fidor; Katarzyna Cekała; Ewa Wieczerzak; Marta Cegłowska; Franciszek Kasprzykowski; Christine Edwards; Hanna Mazur-Marzec
Journal:  Biomolecules       Date:  2021-10-08

Review 4.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.